Nikolaos Lazarinis
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
COMSA-MEWS: a simple quantitative algorithm for determining response to biologics in severe asthma, tested in a real-world mepolizumab study.
Journal: ERJ open research
Published: January 07, 2025
Small airways disease in chronic obstructive pulmonary disease.
Journal: Expert review of respiratory medicine
Published: July 24, 2024
The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?
Journal: ERJ open research
Published: February 02, 2022
COVID-19 vaccination in the setting of mastocytosis-Pfizer-BioNTech mRNA vaccine is safe and well tolerated.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 12, 2021
Allergen provocation tests in respiratory research: building on 50 years of experience.
Journal: The European respiratory journal
Published: October 29, 2021
Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor.
Journal: The Journal of allergy and clinical immunology
Published: September 29, 2017
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses.
Journal: The Journal of allergy and clinical immunology
Published: November 26, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026